English
FranįaisObbligazione Royalty Pharma 1.75% ( US78081BAC72 ) in USD
| Emittente | Royalty Pharma | ||||||
| Prezzo di mercato |  100.42 USD ⇌ |
||||||
| Paese |  Stati Uniti
|
||||||
| Codice isin |
 US78081BAC72 ( in USD )
|
||||||
| Tasso d'interesse | 1.75% per anno ( pagato 2 volte l'anno) | ||||||
| Scadenza | 02/09/2027 | ||||||
| Importo minimo | 2 000 USD | ||||||
| Importo totale | 1 000 000 000 USD | ||||||
| Cusip | 78081BAC7 | ||||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||
| Coupon successivo | 02/03/2027 ( In 129 giorni ) | ||||||
| Descrizione dettagliata |
Royalty Pharma č una societā di investimento biofarmaceutico che acquista diritti di royalty su farmaci giā approvati. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAC72, pays a coupon of 1.75% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 09/02/2027 The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAC72, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAC72, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||